BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 33585982)

  • 1. Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).
    Fisher MJ; Jones DTW; Li Y; Guo X; Sonawane PS; Waanders AJ; Phillips JJ; Weiss WA; Resnick AC; Gosline S; Banerjee J; Guinney J; Gnekow A; Kandels D; Foreman NK; Korshunov A; Ryzhova M; Massimi L; Gururangan S; Kieran MW; Wang Z; Fouladi M; Sato M; Øra I; Holm S; Markham SJ; Beck P; Jäger N; Wittmann A; Sommerkamp AC; Sahm F; Pfister SM; Gutmann DH
    Acta Neuropathol; 2021 Apr; 141(4):605-617. PubMed ID: 33585982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular landscape of glioma in patients with Neurofibromatosis 1.
    D'Angelo F; Ceccarelli M; Tala ; Garofano L; Zhang J; Frattini V; Caruso FP; Lewis G; Alfaro KD; Bauchet L; Berzero G; Cachia D; Cangiano M; Capelle L; de Groot J; DiMeco F; Ducray F; Farah W; Finocchiaro G; Goutagny S; Kamiya-Matsuoka C; Lavarino C; Loiseau H; Lorgis V; Marras CE; McCutcheon I; Nam DH; Ronchi S; Saletti V; Seizeur R; Slopis J; Suñol M; Vandenbos F; Varlet P; Vidaud D; Watts C; Tabar V; Reuss DE; Kim SK; Meyronet D; Mokhtari K; Salvador H; Bhat KP; Eoli M; Sanson M; Lasorella A; Iavarone A
    Nat Med; 2019 Jan; 25(1):176-187. PubMed ID: 30531922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1.
    Lucas CG; Sloan EA; Gupta R; Wu J; Pratt D; Vasudevan HN; Ravindranathan A; Barreto J; Williams EA; Shai A; Whipple NS; Bruggers CS; Maher O; Nabors B; Rodriguez M; Samuel D; Brown M; Carmichael J; Lu R; Mirchia K; Sullivan DV; Pekmezci M; Tihan T; Bollen AW; Perry A; Banerjee A; Mueller S; Gupta N; Hervey-Jumper SL; Oberheim Bush NA; Daras M; Taylor JW; Butowski NA; de Groot J; Clarke JL; Raleigh DR; Costello JF; Phillips JJ; Reddy AT; Chang SM; Berger MS; Solomon DA
    Acta Neuropathol; 2022 Oct; 144(4):747-765. PubMed ID: 35945463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
    Romo CG; Piotrowski AF; Campian JL; Diarte J; Rodriguez FJ; Bale TA; Dahiya S; Gutmann DH; Lucas CG; Prichett L; Mellinghoff I; Blakeley JO
    Neuro Oncol; 2023 Aug; 25(8):1474-1486. PubMed ID: 36840626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromatosis type 1 associated low grade gliomas: A comparison with sporadic low grade gliomas.
    Helfferich J; Nijmeijer R; Brouwer OF; Boon M; Fock A; Hoving EW; Meijer L; den Dunnen WF; de Bont ES
    Crit Rev Oncol Hematol; 2016 Aug; 104():30-41. PubMed ID: 27263935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global microRNA profiling identified miR-10b-5p as a regulator of neurofibromatosis 1 (NF1)-glioma migration.
    Nix JS; Yuan M; Imada EL; Ames H; Marchionni L; Gutmann DH; Rodriguez FJ
    Neuropathol Appl Neurobiol; 2021 Feb; 47(1):96-107. PubMed ID: 32603552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic neurofibromatosis type 1 (NF1) inactivation characterizes NF1-associated pilocytic astrocytoma.
    Gutmann DH; McLellan MD; Hussain I; Wallis JW; Fulton LL; Fulton RS; Magrini V; Demeter R; Wylie T; Kandoth C; Leonard JR; Guha A; Miller CA; Ding L; Mardis ER
    Genome Res; 2013 Mar; 23(3):431-9. PubMed ID: 23222849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonrandomized comparison of neurofibromatosis type 1 and non-neurofibromatosis type 1 children who received carboplatin and vincristine for progressive low-grade glioma: A report from the Children's Oncology Group.
    Ater JL; Xia C; Mazewski CM; Booth TN; Freyer DR; Packer RJ; Sposto R; Vezina G; Pollack IF
    Cancer; 2016 Jun; 122(12):1928-36. PubMed ID: 27061921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.
    Brossier NM; Thondapu S; Cobb OM; Dahiya S; Gutmann DH
    Neuro Oncol; 2021 Apr; 23(4):625-637. PubMed ID: 33080011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling of NF-1-associated and sporadic pilocytic astrocytoma identifies aldehyde dehydrogenase 1 family member L1 (ALDH1L1) as an underexpressed candidate biomarker in aggressive subtypes.
    Rodriguez FJ; Giannini C; Asmann YW; Sharma MK; Perry A; Tibbetts KM; Jenkins RB; Scheithauer BW; Anant S; Jenkins S; Eberhart CG; Sarkaria JN; Gutmann DH
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1194-204. PubMed ID: 19018242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1.
    Leonard JR; Perry A; Rubin JB; King AA; Chicoine MR; Gutmann DH
    Neurology; 2006 Oct; 67(8):1509-12. PubMed ID: 17060590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of astrocytomas presenting after age 10 in individuals with NF1.
    Gutmann DH; James CD; Poyhonen M; Louis DN; Ferner R; Guha A; Hariharan S; Viskochil D; Perry A
    Neurology; 2003 Nov; 61(10):1397-400. PubMed ID: 14638962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.
    Packer RJ; Iavarone A; Jones DTW; Blakeley JO; Bouffet E; Fisher MJ; Hwang E; Hawkins C; Kilburn L; MacDonald T; Pfister SM; Rood B; Rodriguez FJ; Tabori U; Ramaswamy V; Zhu Y; Fangusaro J; Johnston SA; Gutmann DH
    Neuro Oncol; 2020 Jun; 22(6):773-784. PubMed ID: 32055852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.
    Byrne S; Connor S; Lascelles K; Siddiqui A; Hargrave D; Ferner RE
    J Neurooncol; 2017 Jul; 133(3):609-614. PubMed ID: 28593402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
    Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
    Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gliomas in patients with neurofibromatosis type 1.
    Albers AC; Gutmann DH
    Expert Rev Neurother; 2009 Apr; 9(4):535-9. PubMed ID: 19344304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas.
    Wimmer K; Eckart M; Meyer-Puttlitz B; Fonatsch C; Pietsch T
    J Neuropathol Exp Neurol; 2002 Oct; 61(10):896-902. PubMed ID: 12387455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
    Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
    Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
    Dasgupta B; Yi Y; Chen DY; Weber JD; Gutmann DH
    Cancer Res; 2005 Apr; 65(7):2755-60. PubMed ID: 15805275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.